Streetbeat News

Regulatory

CING

Cingulate shares are trading lower following the announcement of the commencement of a final FDA-required food effect study for CTx-1301, a treatment for ADHD.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 4:20 pm

NVDA

SPY

Nvidia CEO Jensen Huang expressed confidence in the Biden administration's decision-making following a White House meeting. He emphasized the importance of American technology in the new industrial revolution.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 4:13 pm

F

GM

TSLA

Automakers express concerns over a proposed bill that would tighten restrictions on Chinese content for electric vehicle tax credits, potentially requiring a rollback of emissions rules.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 4:10 pm

SPY

The CDC confirmed that a Missouri bird flu patient was not severely ill and was treated with antivirals. The USDA reported eight California dairy herds tested positive for bird flu, all quarantined. Bird flu vaccine field studies in cattle are set to begin.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 4:09 pm

BTCUSD

Travis Kling, CIO at Ikigai Asset Management, highlights a 'Quiet Quitting' trend in the crypto industry, with decreased engagement and disillusionment among professionals. He attributes this to unmet promises of crypto projects and warns of potential deterrence for new talent. Despite a bearish outlook, Kling sees potential regulatory changes as a path to sustainable growth.

Portfolio Pulse from Khyathi Dalal

September 12, 2024 | 4:06 pm

CNEY

CN Energy's shares are declining following a noncompliance notice from Nasdaq, indicating potential issues with listing requirements.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 3:52 pm

BTCUSD

A Deutsche Bank report reveals growing acceptance of cryptocurrency among U.S. consumers, with 65% believing it could replace cash. The report highlights mixed predictions for Bitcoin's future and uncertain prospects for stablecoins. The findings suggest potential growth in crypto adoption.

Portfolio Pulse from Murtuza Merchant

September 12, 2024 | 3:40 pm

AURA

Aura Biosciences reported promising Phase 2 results for its eye cancer treatment, bel-sar, showing an 80% tumor control rate and high visual acuity preservation. The treatment has a favorable safety profile and has received FDA agreement for a Phase 3 trial. Aura's stock rose 6.39% following the news.

Portfolio Pulse from Vandana Singh

September 12, 2024 | 3:40 pm

AMZN

WMT

An Indian antitrust investigation has found that Amazon and Walmart's Flipkart breached competition laws by favoring select sellers, which hurt competition and created an ecosystem where only their preferred sellers could survive.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 3:39 pm

LFLY

Leafly (NASDAQ:LFLY) has partnered with the New York Cannabis Retail Association to support the legal cannabis market in New York. The partnership aims to promote legal cannabis through industry events and marketing initiatives, addressing the challenges posed by unlicensed cannabis shops.

Portfolio Pulse from Jelena Martinovic

September 12, 2024 | 3:34 pm